A hepatitis B surface antibody level of 10 mIU/mL or higher is considered protective, meaning your immune system can fight off a hepatitis B infection. A result below 10 mIU/mL is classified as non-reactive, indicating you may not have adequate protection against the virus. This threshold is the standard used by the CDC and labs worldwide.
What the Numbers Mean
The hepatitis B surface antibody test (sometimes written as anti-HBs) is a quantitative blood test that measures how many antibodies your body has produced against the outer surface of the hepatitis B virus. Results are reported in mIU/mL, and the cutoff is straightforward:
- Below 10 mIU/mL: Non-reactive. You are not considered immune and may be susceptible to infection.
- 10 mIU/mL or above: Reactive. You have protective immunity, either from vaccination or from a past infection your body successfully cleared.
There is no upper limit to worry about. Some people produce antibody levels in the hundreds or even thousands after vaccination, and higher numbers simply reflect a strong immune response. The key question is whether you’re above or below that 10 mIU/mL line.
Vaccination Immunity vs. Natural Immunity
Your antibody result alone doesn’t tell the full story. To understand how you became immune, doctors look at a second marker called the core antibody (anti-HBc), which only appears after actual infection with the virus, not after vaccination.
If your surface antibody is positive but your core antibody is negative, your immunity came from the hepatitis B vaccine. If both are positive (and you test negative for the surface antigen, HBsAg), it means you were infected at some point, your body cleared the virus, and you’re now immune from that natural exposure. This distinction matters for medical records and donor screening but doesn’t change the fact that you’re protected either way.
Why Levels Drop Over Time
It’s common for surface antibody levels to decline years after vaccination, sometimes falling below 10 mIU/mL or even becoming undetectable. This does not necessarily mean you’ve lost protection. Research tracking vaccinated healthcare workers for up to 30 years shows that immunological memory of hepatitis B remains intact for at least three decades, even when measurable antibody levels have faded.
The reason is that your immune system retains memory cells capable of rapidly producing new antibodies if you’re ever exposed to the virus. This is called an anamnestic response: your body recognizes the threat and mounts a defense fast enough to prevent infection. For immunocompetent people who responded to the initial vaccine series, this protection holds even if a later blood test shows antibody levels below the detectable range.
Who Needs This Test
Most people who were vaccinated as children never need their antibody levels checked. Titer testing is typically reserved for people whose immune status has practical consequences. Healthcare workers are the most common group, since they face occupational exposure to blood and need documented proof of immunity. Others who may need testing include household or sexual contacts of someone with chronic hepatitis B, people with weakened immune systems, and infants born to mothers who tested positive for the virus during pregnancy.
If you’re getting this test as part of a job requirement or school enrollment, the threshold you need to meet is the same: 10 mIU/mL or above.
What Happens If Your Level Is Too Low
A result below 10 mIU/mL after a complete vaccine series doesn’t always mean the vaccine failed. If your original vaccination was years ago, it may simply reflect the natural decline of circulating antibodies while your underlying immune memory is still intact. In this situation, the standard approach is to give a single booster dose and then recheck your levels four to eight weeks later.
If the booster brings your antibody level to 10 mIU/mL or above, you’re confirmed immune. If it doesn’t, you’re considered a vaccine non-responder. Non-responders are first tested for active hepatitis B infection to rule out a chronic carrier state. If that test is negative, the recommendation is to receive two additional doses of vaccine spaced one month apart, then retest after the final dose. A small percentage of people never mount an adequate antibody response despite multiple rounds of vaccination. These individuals are considered susceptible and should be aware that post-exposure treatment is available if they come into contact with the virus.
Reading Your Full Panel
The surface antibody test is most useful when interpreted alongside other hepatitis B markers. Here’s a quick reference for common result combinations:
- All markers negative: Never infected, no immunity. You’re susceptible and should consider vaccination.
- Surface antibody positive, everything else negative: Immune from vaccination.
- Surface antibody positive, core antibody positive, surface antigen negative: Immune from a past natural infection that your body cleared.
- Surface antigen positive, core antibody positive, surface antibody negative: Chronic hepatitis B infection. The virus is still active.
The surface antigen (HBsAg) is a completely different test from the surface antibody. The antigen is a piece of the virus itself and signals active infection. The antibody is produced by your immune system in response to the virus or a vaccine. Seeing both terms on a lab order can be confusing, but they answer opposite questions: the antigen asks “is the virus present?” while the antibody asks “can your body fight it off?”